The Ohio State University Cancer Research Center was established in 1973 and received National Cancer Institute designation in April 1976 as a comprehensive cancer center (OSUCCC). The patient care arm of the OSUCCC is the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. The center is known as the OSUCCC – James.
The OSUCCC – James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers that develops clinical practice guidelines to improve the quality of care.
The OSUCCC – James comprises five interactive cancer research programs: Cancer Control, Leukemia, Molecular Biology and Cancer Genetics, Molecular Carcinogenesis and Chemoprevention and Translational Therapeutics. Engaged in this research are more than 300 center members from 12 of the 14 colleges at Ohio State and affiliated academic institutions, including scientists and physicians from multiple specialties. Their work contributes to the center’s larger mission to eradicate cancer from individuals’ lives by generating knowledge and integrating groundbreaking research with excellence in education and patient-centered care.
Within the James Cancer Hospital and Solove Research Institute, the OSUCCC – James can rapidly translate the latest cancer research discoveries to innovative cancer care and prevention strategies. A multidisciplinary, high-technology and multimodality approach to cancer care includes disease site groups with surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, researchers and other experts collaborating to provide the latest in cancer diagnosis, treatment and prevention.
In December 2014, the OSUCCC – James opened a new James Cancer Hospital and Solove Research Institute. With 21 floors, 1.1 million square feet and 306 beds in private rooms, the new James ranks as the third-largest cancer hospital in the nation – a transformational facility that is designed to integrate researchers, clinicians and educators more closely than ever before and enhance science-based patient care.
The hospital includes a 36-bed blood and marrow transplant unit, inpatient units in which sub-specialists focus on just one type of cancer, a cancer clinical trials unit, 14 state-of-the-art operating rooms, six interventional radiology suites, special isolation rooms, chemotherapy and transfusion areas, seven linear accelerators for radiation therapy, an above-ground radiation oncology department that enables patients to benefit from the calming and healing effects of natural light and a fully integrated cancer emergency department for treating cancer-related medical emergencies.
This concentration of cancer research and care has led the OSUCCC – James to become one of only a few cancer centers awarded contracts by the NCI to conduct both phase I and phase II clinical trials on new NCI-sponsored anticancer drugs. Those trials take place in inpatient and outpatient facilities at the center.
Ambulatory patients access services from a variety of outpatient facilities on campus and across central Ohio. Among the many locations, Ohio State’s Stefanie Spielman Comprehensive Breast Center, which opened in 2011, provides the full spectrum of breast care and other women-focused oncology programs. Overall, the OSUCCC – James has more than 1.5 million square feet of clinical and research space to facilitate the translation of discovery to treatment.
Finally, the OSUCCC – James’ outreach to underserved populations includes its work with the Appalachia Community Cancer Network and an effort by the Centers for Population Health and Health Disparities to understand the reasons for high rates of cervical cancer incidence and mortality in Appalachian Ohio.